BioNote Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Revenue	95,081	90,081	479,657	622,355	631,505	40,047
Other Revenue	0	0	-0	-0	-	-
Revenue	95,081	90,081	479,657	622,355	631,505	40,047
Revenue Growth (YoY)	-27.96%	-81.22%	-22.93%	-1.45%	1476.89%	-
Cost of Revenue	48,205	101,739	139,186	110,352	51,950	21,345
Gross Profit	46,876	-11,659	340,471	512,003	579,554	18,703
Selling, General & Admin	22,110	22,787	31,519	24,340	13,102	5,051
Research & Development	13,121	13,405	16,138	11,300	7,612	3,628
Other Operating Expenses	199.56	168.12	176.92	345.29	45.46	30.88
Operating Expenses	32,464	35,510	45,062	43,255	21,523	8,775
Operating Income	14,412	-47,168	295,410	468,748	558,031	9,928
Interest Expense	-676.15	-602.82	-84.44	-44.25	-172.63	-468.26
Interest & Investment Income	21,081	24,630	9,715	873.63	37.56	43.83
Earnings From Equity Investments	-	-	-147,264	-	-	-
Currency Exchange Gain (Loss)	21,698	10,164	24,512	24,159	-5,726	272.84
Other Non Operating Income (Expenses)	178.77	420.84	-296.63	-123.11	-75.83	-2.81
EBT Excluding Unusual Items	56,693	-12,556	181,992	493,612	552,094	9,774
Gain (Loss) on Sale of Investments	-31,069	-88,791	219,374	376,239	143,115	-826.93
Gain (Loss) on Sale of Assets	152.19	265.2	13,412	33.39	-11.45	16,271
Asset Writedown	-	-8,409	-	-	-	-
Pretax Income	25,777	-109,491	414,778	869,885	695,198	25,218
Income Tax Expense	-55,874	-88,994	106,980	193,284	166,969	4,605
Net Income	81,651	-20,497	307,798	676,601	528,229	20,613
Net Income to Common	81,651	-20,497	307,798	676,601	528,229	20,613
Net Income Growth	-	-	-54.51%	28.09%	2462.62%	-
Shares Outstanding (Basic)	102	102	94	94	94	84
Shares Outstanding (Diluted)	102	102	94	94	94	84
Shares Change (YoY)	4.14%	8.29%	0.64%	0.14%	11.08%	-
EPS (Basic)	800.17	-200.99	3277.21	7232.04	5646.12	244.74
EPS (Diluted)	798.94	-201.00	3264.00	7222.00	5646.00	244.74
EPS Growth	-	-	-54.80%	27.91%	2206.94%	-
Free Cash Flow	42,930	-8,156	206,834	485,966	213,228	8,333
Free Cash Flow Per Share	420.19	-79.88	2193.65	5186.94	2279.15	98.94
Dividend Per Share	200.000	200.000	-	-	-	-
Gross Margin	49.30%	-12.94%	70.98%	82.27%	91.77%	46.70%
Operating Margin	15.16%	-52.36%	61.59%	75.32%	88.37%	24.79%
Profit Margin	85.88%	-22.75%	64.17%	108.72%	83.65%	51.47%
Free Cash Flow Margin	45.15%	-9.05%	43.12%	78.09%	33.77%	20.81%
EBITDA	22,516	-38,962	301,861	472,854	559,918	11,338
EBITDA Margin	23.68%	-43.25%	62.93%	75.98%	88.66%	28.31%
D&A For EBITDA	8,104	8,206	6,451	4,106	1,887	1,410
EBIT	14,412	-47,168	295,410	468,748	558,031	9,928
EBIT Margin	15.16%	-52.36%	61.59%	75.32%	88.37%	24.79%
Effective Tax Rate	-	-	25.79%	22.22%	24.02%	18.26%
Advertising Expenses	-	2,414	2,332	1,063	540.13	354.15

Source: S&P Capital IQ. Standard template. Financial Sources.